Article(id=1329913758534709902, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1329913746920681993, articleNumber=null, orderNo=null, doi=10.13683/j.wph.2018.10.004, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1527177600000, receivedDateStr=2018-05-25, revisedDate=1535472000000, revisedDateStr=2018-08-29, acceptedDate=null, acceptedDateStr=null, onlineDate=1795005748636, onlineDateStr=2026-11-18, pubDate=1539100800000, pubDateStr=2018-10-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1795005748636, onlineIssueDateStr=2026-11-18, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1795005748636, creator=13701087609, updateTime=1795005748636, updator=13701087609, issue=Issue{id=1329913746920681993, tenantId=1146029695717560320, journalId=1319690329412173987, year='2018', volume='39', issue='10', pageStart='649', pageEnd='720', issueExtLink='null', onlineDate='null', pubDate='1539100800000', pubDateStr='2018-10-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1795005745868, creator='13701087609', updateTime=1795056465582, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1330126481231033225, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1329913746920681993, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1330126481231033226, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1329913746920681993, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=666, endPage=670, ext={EN=ArticleExt(id=1329913758719259279, articleId=1329913758534709902, tenantId=1146029695717560320, journalId=1319690329412173987, language=EN, title=Advances in drug therapy for anti-neutrophil cytoplasmic antibody associated vasculitis and renal damage, columnId=1325221107665612978, journalTitle=World Clinical Drug, columnName=Topic, runingTitle=null, highlight=null, articleAbstract=

Anti-neutrophil cytoplasmic antibody (ANCA) associated vasculitis (AAV) is a necrotizing vasculitis caused by the activation of ANCA through anti-neutrophil antibody, which often affects the kidney. In general, the glucocorticoid combined with immunosuppressive agents is the most basic and commonly used treatment for systemic vasculitis. This article reviews AAV and its renal damage, including the clinical evaluation of immunosuppressive therapy and biotherapy drugs.

, authors=Xiao-rong BAO, authorsList=Xiao-rong BAO, authorCompany=null, correspAuthors=null, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1329913759247741585, articleId=1329913758534709902, tenantId=1146029695717560320, journalId=1319690329412173987, language=CN, title=抗中性粒细胞胞浆抗体相关性血管炎及其肾损害的药物治疗进展, columnId=1329913747923120651, journalTitle=世界临床药物, columnName=医药专论·结缔组织疾病相关性肾损害专题, runingTitle=null, highlight=null, articleAbstract=

抗中性粒细胞胞浆抗体(ANCA)相关性血管炎(AAV)发病机制主要是由抗中性粒细胞抗体激活ANCA而导致的坏死性血管炎,常常累及肾脏。糖皮质激素联合免疫抑制剂是系统性血管炎最基本和常用的治疗方法。本文综述AAV及其肾损害的免疫抑制治疗和生物治疗药物的临床应用评价。

, authors=鲍晓荣, authorsList=鲍晓荣, authorCompany=null, correspAuthors=null, authorNote=

鲍晓荣,主任医师,研究方向:肾脏疾病的临床诊治。

, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=P5hDohrZu+O3Pi48yThM2w==, magXml=l9v9JLRWB5k6WrlS6ae1VQ==, pdfUrl=null, pdf=14i1vqt8cEjrm06WSbKmBQ==, pdfFileSize=918097, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=NnsLPnm85Sj0E4MDEUDNdw==, mapNumber=null, fund=null)}, authors=[Author(id=1329913759621034646, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913758534709902, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329913759734280856, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913758534709902, authorId=1329913759621034646, language=EN, stringName=Xiao-rong BAO, firstName=Xiao-rong, middleName=null, lastName=BAO, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Department of Nephrology, Jinshan Hospital of Fudan University, Shanghai 201508, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329913759818166937, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913758534709902, authorId=1329913759621034646, language=CN, stringName=鲍晓荣, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=复旦大学附属金山医院肾内科,上海 201508, bio={"content":"

鲍晓荣,主任医师,研究方向:肾脏疾病的临床诊治。

"}, bioImg=null, bioContent=

鲍晓荣,主任医师,研究方向:肾脏疾病的临床诊治。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329913759499399826, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913758534709902, xref=null, ext=[AuthorCompanyExt(id=1329913759511982739, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913758534709902, companyId=1329913759499399826, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Nephrology, Jinshan Hospital of Fudan University, Shanghai 201508, China), AuthorCompanyExt(id=1329913759524565652, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913758534709902, companyId=1329913759499399826, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=复旦大学附属金山医院肾内科,上海 201508)])])], keywords=[Keyword(id=1329913759906247322, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913758534709902, language=EN, orderNo=1, keyword=anti-neutrophil cytoplasmic antibody (ANCA)), Keyword(id=1329913760023687835, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913758534709902, language=EN, orderNo=2, keyword=vasculitis), Keyword(id=1329913760094991004, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913758534709902, language=EN, orderNo=3, keyword=renal damage), Keyword(id=1329913760162099869, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913758534709902, language=CN, orderNo=1, keyword=抗中性粒细胞胞浆抗体(ANCA)), Keyword(id=1329913760220820126, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913758534709902, language=CN, orderNo=2, keyword=血管炎), Keyword(id=1329913760279540383, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913758534709902, language=CN, orderNo=3, keyword=肾损害)], refs=[Reference(id=1329913760363426464, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913758534709902, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=肖会, 徐建华. 系统性血管炎钙素与分类[J]. 临床内科杂志, 2014, 31(10): 653-655., articleTitle=null, refAbstract=null), Reference(id=1329913760426341025, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913758534709902, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=Watts RA, Mooney J, Skinner J, et al. The contrasting epidemiology of granulomatosis with polyangiitis (Wegener's) and microscopic polyangiitis[J]. Rheumatology (Oxford), 2012, 51(5): 926-931., articleTitle=null, refAbstract=null), Reference(id=1329913760480866978, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913758534709902, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=刘霞, 胡伟新. 抗中性粒细胞胞浆抗体相关性血管炎的临床研究进展[J]. 医学研究生学报, 2016, 29(3): 323-326., articleTitle=null, refAbstract=null), Reference(id=1329913760543781539, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913758534709902, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=Hu W, Liu C, Xie H, et al. Mycophenolate mofetil versus cyclophosphamide for inducing remission of ANCA vasculitis with moderate renal involvement[J]. Nephrol Dial Transplant, 2008, 23(4): 1307-1312., articleTitle=null, refAbstract=null), Reference(id=1329913760606696100, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913758534709902, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=De Groot K, Rasmussen N, Bacon PA, et al. Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis[J]. Arthritis Rheum, 2005, 52(8): 2461-2469., articleTitle=null, refAbstract=null), Reference(id=1329913760661222053, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913758534709902, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=Jayne D, Rasmussen N, Andrassy K, et al. A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies[J]. N Engl J Med, 2003, 349(1): 36-44., articleTitle=null, refAbstract=null), Reference(id=1329913760753496742, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913758534709902, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=Metzler C, Fink C, Lamprecht P, et al. Maintenance of remission with leflunomide in Wegener's grunulomatosis[J]. Rhenmatology (Oxford), 2004, 43(3): 315-320., articleTitle=null, refAbstract=null), Reference(id=1329913760841577127, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913758534709902, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=Lapraik C, Watts R, Bacon P, et al. BSR and BHPR guidelines for the management of adults with ANCA associated vasctditis[J]. Rhenmatology (Oxford), 2007, 46(10): 1615-1616., articleTitle=null, refAbstract=null), Reference(id=1329913760929657512, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913758534709902, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=王霞, 胡伟新. 利妥昔单抗在抗中性粒细胞胞质抗体相关性血管炎治疗中的应用[J]. 肾脏病与透析肾移植杂志, 2015, 24(3): 275-279., articleTitle=null, refAbstract=null), Reference(id=1329913760996766377, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913758534709902, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=Roccatello D, Baldovino S, Alpa M, et al. Effects of anti-CD20 monoclonal antibody as a rescue treatment for ANCA associated idiopathic systemic vasculitis with or without overt renaL involvement[J]. Clin Exp Rheumato1, 2008, 26(Supp1 49): 67-71., articleTitle=null, refAbstract=null), Reference(id=1329913761068069546, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913758534709902, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=Smith K, Jones R, Burns S, et al. Long-term comparison of rituximab treatment for refractory systemic lupus erythematosus and vasculitis: remission, relapse, and retreatment[J]. Arthritis Rhedm, 2006, 54(9): 2970-2982., articleTitle=null, refAbstract=null), Reference(id=1329913761151955627, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913758534709902, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=Jones RB, Tervacrt JW, Hauser T, et al. Rituximab versus cyclophosphamide in ANCA-associated renal vaseulitis[J]. N Engl J Med, 2010, 363(3): 211-220., articleTitle=null, refAbstract=null), Reference(id=1329913761235841708, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913758534709902, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=Jones RB, Ferraro AJ, Chaudhry AN, et al. A multicenter survey of rituximab therapy for refractory antineutrophil cytoplasmic antibody-associated vasculitis[J]. Arthritis Rheum, 2009, 60(7): 2156-2168., articleTitle=null, refAbstract=null), Reference(id=1329913761307144877, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913758534709902, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=曾玲玲, 胡章学. 相关性小血管炎诱导缓解治疗进展[J]. 中国中西医结合肾病杂志, 2015, 16(1): 85-86., articleTitle=null, refAbstract=null), Reference(id=1329913761370059438, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913758534709902, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=Stone JH, Merkel PA, Spiera R, et al. Rituximab versus cyclophosphamide for ANCA-associated vasculitis[J]. N Engl J Med, 2010, 363(3): 221-232., articleTitle=null, refAbstract=null), Reference(id=1329913761432973999, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913758534709902, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=Specks U, Merkel PA, Seo P, et al. Efficacy of remission-induction regimens for ANCA- regimens for ANCA-associated vasculitis[J]. N Engl J Med, 2013, 369(5): 417-427., articleTitle=null, refAbstract=null), Reference(id=1329913761508471472, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913758534709902, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=Guerry MJ, Brogan P, Bruce IN, et al. Recommendations for the use of rituximab in anti-neutrophil cytoplasm antibody-associated vasculitie[J]. Rheumatology (Oxford), 2012, 51(4): 634-643., articleTitle=null, refAbstract=null), Reference(id=1329913761567191729, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913758534709902, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=Charles P, Bienvenu B, Bonnotte B, et al. Rituximab: recommendations of the French vasculitis study group (FVSG) for induction and maintenance treatments of adult, antineutrophil cytoplasm antibody-associated necrotizing vasculitides[J]. Presse Med, 2013, 42(10): 1317-1330., articleTitle=null, refAbstract=null), Reference(id=1329913761630106290, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913758534709902, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=Josselin L, Mahr A, Cohen P, et al. Infliximab efficacy and safety against refractory systemic becrotising vasculitides: long-term follow-up of 15 patients[J]. Ann Rheum Dis, 2008, 67(9): 1343-1346., articleTitle=null, refAbstract=null), Reference(id=1329913761760129715, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913758534709902, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=null, journalName=null, refType=null, unstructuredReference=Morgan MD, Drayson MT, Savage CO, et al. Addition of inflixinab to standard therapy for ANCA-associated vasculitis[J]. Nephron Clin Pract, 2011, 117(2): c89-c97., articleTitle=null, refAbstract=null), Reference(id=1329913761827238580, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913758534709902, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[21], rfOrder=20, authorNames=null, journalName=null, refType=null, unstructuredReference=Ramos-Casals M, Brito-Zeron P, Munoz S, et al. A systematic review of the off-label use of biological therapies in systemic autoimmune diseases[J]. Medicine (Baltimore), 2008, 87(6): 345-364., articleTitle=null, refAbstract=null), Reference(id=1329913761911124661, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913758534709902, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[22], rfOrder=21, authorNames=null, journalName=null, refType=null, unstructuredReference=Chen TJ, Yang YF, Huang PH, et al. Permanent renal loss following tumor necrosis factor-α antagonists for arthritis[J]. Rheumatol Int, 2010, 30(8): 1077-1079., articleTitle=null, refAbstract=null), Reference(id=1329913762028565174, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913758534709902, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[23], rfOrder=22, authorNames=null, journalName=null, refType=null, unstructuredReference=Walsh M, Chaudhry A, Jayne D. Long-term follow-up of relapsing/refractory anti-neutrophil cytoplasm antibody associated vasculitis treated with the lymphocyte depleting antibody alemtuzumab (CAMPATH-IH)[J]. Ann Rheum Dis, 2008, 67(9): 322-327., articleTitle=null, refAbstract=null), Reference(id=1329913762104062647, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913758534709902, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[24], rfOrder=23, authorNames=null, journalName=null, refType=null, unstructuredReference=Schmitt WH, Hagen EC, Neumann I, et al. Treatment of refractory Wegener's granulomatosis with antithymocyte globulin (ATG): an open study in 15 patients[J]. Kidney Int, 2004, 65(4): 1440-1448., articleTitle=null, refAbstract=null), Reference(id=1329913762183754424, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913758534709902, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[25], rfOrder=24, authorNames=null, journalName=null, refType=null, unstructuredReference=Kim S, Marigowda G, Oren E, et al. Mepolizumab as a steroid-sparing treatment option in patients with Churg-Strauss syndrome[J]. J Allergy Clin Immunol, 2010, 125(6): 1336-1343., articleTitle=null, refAbstract=null), Reference(id=1329913762255057593, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913758534709902, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[26], rfOrder=25, authorNames=null, journalName=null, refType=null, unstructuredReference=Stone JH, Uhlfelder ML, Hellmann DB, et al. Etanercept combined with conventional treatment in Wegener's granulomatosis: a six-month open-label trial to evaluate safety[J]. Arthritis Rheum, 2001, 44(5): 1149-1154., articleTitle=null, refAbstract=null), Reference(id=1329913762334749370, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913758534709902, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[27], rfOrder=26, authorNames=null, journalName=null, refType=null, unstructuredReference=Wegener's Granulomatosis Etanercept Trial (WGET) research group. Ertanercept plus standard therapy for Wegener's granulomatosi[J]. N Engl J Med, 2005, 352(4): 351-361., articleTitle=null, refAbstract=null), Reference(id=1329913762406052539, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913758534709902, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[28], rfOrder=27, authorNames=null, journalName=null, refType=null, unstructuredReference=Laurino S, Chaudhry A, Booth A, et al. Prospective study of TNFalpha blockade with adalimumab in ANCA-associated systemic vasculitis with renal involvement[J]. Nephrol Dial Transplant, 2010, 25(10): 3307-3314., articleTitle=null, refAbstract=null)], funds=null, companyList=[AuthorCompany(id=1329913759499399826, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913758534709902, xref=null, ext=[AuthorCompanyExt(id=1329913759511982739, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913758534709902, companyId=1329913759499399826, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Nephrology, Jinshan Hospital of Fudan University, Shanghai 201508, China), AuthorCompanyExt(id=1329913759524565652, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913758534709902, companyId=1329913759499399826, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=复旦大学附属金山医院肾内科,上海 201508)])], figs=null, attaches=null, journal=Journal(id=1319689997550452896, delFlag=0, nameCn=世界临床药物, nameEn=World Clinical Drug, nameHistory1=null, nameHistory2=null, issn=1672-9188, eissn=null, cn=31-1939/R, coden=SLYHAA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=9c6IkcJKa1cF20h1u6lJeQ==, journalPrice=null, startedYear=null, abbrevIsoEn=World Clinical Drug, journalRemark=null, publicationField=null, createdTime=1792568214072, updatedTime=1792747519563, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=S, firstLetterEn=S, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=9c6IkcJKa1cF20h1u6lJeQ==, picEn=MRqUlTwfL6oqIHNy7eyFZQ==, jcr=null, cjcr=null, exts=[JournalExt(id=1320442059660570919, language=CN, name=世界临床药物, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519650, updatedTime=1792747519650, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""}), JournalExt(id=1320442059723485480, language=EN, name=World Clinical Drug, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519665, updatedTime=1792747519665, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""})], databaseList=null, tenantJournalId=1319690329412173987, websiteList=[Website(id=1321427104911179915, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/CN, language=CN, createTime=1792982372739, createBy=18614031015, updateTime=1792982514949, updateBy=18614031015, name=世界临床药物-中文, tplId=1146099689490845704, title=世界临床药物, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428428256031726, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=articleTextType, value=kx, createTime=1792982688249, updateTime=1792982688249, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428193117163, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982688234, updateTime=1792982688234, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428302169073, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=grayFlag, value=0, createTime=1792982688260, updateTime=1792982688260, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428172145642, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982688229, updateTime=1792982688229, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428327334899, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=minRunFlag, value=0, createTime=1792982688266, updateTime=1792982688266, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428226671597, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic, createTime=1792982688242, updateTime=1792982688242, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428314751986, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=silenceFlag, value=0, createTime=1792982688263, updateTime=1792982688263, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428209894380, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982688238, updateTime=1792982688238, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428268614639, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeColor, value=null, createTime=1792982688252, updateTime=1792982688252, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428289586160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982688257, updateTime=1792982688257, creator=18614031015, updator=18614031015)]), Website(id=1321427104990871693, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/EN, language=EN, createTime=1792982372758, createBy=18614031015, updateTime=1792982556355, updateBy=18614031015, name=世界临床药物-英文, tplId=1146101810881728533, title=World Clinical Drug, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428446820021244, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=articleTextType, value=kx, createTime=1792982692675, updateTime=1792982692675, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446757106681, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982692660, updateTime=1792982692660, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447109428223, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=grayFlag, value=0, createTime=1792982692744, updateTime=1792982692744, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446736135160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982692655, updateTime=1792982692655, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447142981632, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=minRunFlag, value=0, createTime=1792982692752, updateTime=1792982692752, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446790661115, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic, createTime=1792982692668, updateTime=1792982692668, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447130399745, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=silenceFlag, value=0, createTime=1792982692749, updateTime=1792982692749, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446769689594, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982692663, updateTime=1792982692663, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446832604157, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeColor, value=null, createTime=1792982692678, updateTime=1792982692678, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447092651006, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982692740, updateTime=1792982692740, creator=18614031015, updator=18614031015)])], journalTitle=世界临床药物, weixinUrl=null, journalUrl=http://www.jwph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=World Clinical Drug, journalPhotoCn=9c6IkcJKa1cF20h1u6lJeQ==, journalPhotoEn=MRqUlTwfL6oqIHNy7eyFZQ==, journalFirstLetter=S, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2018.10.004, detailUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2018.10.004, pdfUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/PDF/10.13683/j.wph.2018.10.004, pdfUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/PDF/10.13683/j.wph.2018.10.004, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1539100800000, fullTextJson=null, articleText=null, reference=null)
收藏切换
抗中性粒细胞胞浆抗体相关性血管炎及其肾损害的药物治疗进展
鲍晓荣
世界临床药物 | 医药专论·结缔组织疾病相关性肾损害专题 2018,39(10): 666-670
收起
收藏切换
世界临床药物 |医药专论·结缔组织疾病相关性肾损害专题 2018 , 39 (10) : 666 -670
抗中性粒细胞胞浆抗体相关性血管炎及其肾损害的药物治疗进展
全屏
[Author(id=1329913759621034646, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913758534709902, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329913759734280856, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913758534709902, authorId=1329913759621034646, language=EN, stringName=Xiao-rong BAO, firstName=Xiao-rong, middleName=null, lastName=BAO, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Department of Nephrology, Jinshan Hospital of Fudan University, Shanghai 201508, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329913759818166937, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913758534709902, authorId=1329913759621034646, language=CN, stringName=鲍晓荣, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=复旦大学附属金山医院肾内科,上海 201508, bio={"content":"

鲍晓荣,主任医师,研究方向:肾脏疾病的临床诊治。

"}, bioImg=null, bioContent=

鲍晓荣,主任医师,研究方向:肾脏疾病的临床诊治。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329913759499399826, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913758534709902, xref=null, ext=[AuthorCompanyExt(id=1329913759511982739, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913758534709902, companyId=1329913759499399826, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Nephrology, Jinshan Hospital of Fudan University, Shanghai 201508, China), AuthorCompanyExt(id=1329913759524565652, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913758534709902, companyId=1329913759499399826, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=复旦大学附属金山医院肾内科,上海 201508)])])]
鲍晓荣
作者信息
  • 复旦大学附属金山医院肾内科,上海 201508
作者简介:

鲍晓荣,主任医师,研究方向:肾脏疾病的临床诊治。

Advances in drug therapy for anti-neutrophil cytoplasmic antibody associated vasculitis and renal damage
Xiao-rong BAO
Affiliations
  • Department of Nephrology, Jinshan Hospital of Fudan University, Shanghai 201508, China
出版时间: 2018-10-10 doi: 10.13683/j.wph.2018.10.004
文章导航
收藏切换

抗中性粒细胞胞浆抗体(ANCA)相关性血管炎(AAV)发病机制主要是由抗中性粒细胞抗体激活ANCA而导致的坏死性血管炎,常常累及肾脏。糖皮质激素联合免疫抑制剂是系统性血管炎最基本和常用的治疗方法。本文综述AAV及其肾损害的免疫抑制治疗和生物治疗药物的临床应用评价。

抗中性粒细胞胞浆抗体(ANCA)  /  血管炎  /  肾损害

Anti-neutrophil cytoplasmic antibody (ANCA) associated vasculitis (AAV) is a necrotizing vasculitis caused by the activation of ANCA through anti-neutrophil antibody, which often affects the kidney. In general, the glucocorticoid combined with immunosuppressive agents is the most basic and commonly used treatment for systemic vasculitis. This article reviews AAV and its renal damage, including the clinical evaluation of immunosuppressive therapy and biotherapy drugs.

anti-neutrophil cytoplasmic antibody (ANCA)  /  vasculitis  /  renal damage
鲍晓荣. 抗中性粒细胞胞浆抗体相关性血管炎及其肾损害的药物治疗进展. 世界临床药物, 2018 , 39 (10) : 666 -670 . DOI: 10.13683/j.wph.2018.10.004
Xiao-rong BAO. Advances in drug therapy for anti-neutrophil cytoplasmic antibody associated vasculitis and renal damage[J]. World Clinical Drug, 2018 , 39 (10) : 666 -670 . DOI: 10.13683/j.wph.2018.10.004

参考文献 引证文献
排序方式:
[1]
肖会, 徐建华. 系统性血管炎钙素与分类[J]. 临床内科杂志, 2014, 31(10): 653-655.
[2]
Watts RA, Mooney J, Skinner J, et al. The contrasting epidemiology of granulomatosis with polyangiitis (Wegener's) and microscopic polyangiitis[J]. Rheumatology (Oxford), 2012, 51(5): 926-931.
[3]
刘霞, 胡伟新. 抗中性粒细胞胞浆抗体相关性血管炎的临床研究进展[J]. 医学研究生学报, 2016, 29(3): 323-326.
[4]
Hu W, Liu C, Xie H, et al. Mycophenolate mofetil versus cyclophosphamide for inducing remission of ANCA vasculitis with moderate renal involvement[J]. Nephrol Dial Transplant, 2008, 23(4): 1307-1312.
[5]
De Groot K, Rasmussen N, Bacon PA, et al. Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis[J]. Arthritis Rheum, 2005, 52(8): 2461-2469.
[6]
Jayne D, Rasmussen N, Andrassy K, et al. A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies[J]. N Engl J Med, 2003, 349(1): 36-44.
[7]
Metzler C, Fink C, Lamprecht P, et al. Maintenance of remission with leflunomide in Wegener's grunulomatosis[J]. Rhenmatology (Oxford), 2004, 43(3): 315-320.
[8]
Lapraik C, Watts R, Bacon P, et al. BSR and BHPR guidelines for the management of adults with ANCA associated vasctditis[J]. Rhenmatology (Oxford), 2007, 46(10): 1615-1616.
[9]
王霞, 胡伟新. 利妥昔单抗在抗中性粒细胞胞质抗体相关性血管炎治疗中的应用[J]. 肾脏病与透析肾移植杂志, 2015, 24(3): 275-279.
[10]
Roccatello D, Baldovino S, Alpa M, et al. Effects of anti-CD20 monoclonal antibody as a rescue treatment for ANCA associated idiopathic systemic vasculitis with or without overt renaL involvement[J]. Clin Exp Rheumato1, 2008, 26(Supp1 49): 67-71.
[11]
Smith K, Jones R, Burns S, et al. Long-term comparison of rituximab treatment for refractory systemic lupus erythematosus and vasculitis: remission, relapse, and retreatment[J]. Arthritis Rhedm, 2006, 54(9): 2970-2982.
[12]
Jones RB, Tervacrt JW, Hauser T, et al. Rituximab versus cyclophosphamide in ANCA-associated renal vaseulitis[J]. N Engl J Med, 2010, 363(3): 211-220.
[13]
Jones RB, Ferraro AJ, Chaudhry AN, et al. A multicenter survey of rituximab therapy for refractory antineutrophil cytoplasmic antibody-associated vasculitis[J]. Arthritis Rheum, 2009, 60(7): 2156-2168.
[14]
曾玲玲, 胡章学. 相关性小血管炎诱导缓解治疗进展[J]. 中国中西医结合肾病杂志, 2015, 16(1): 85-86.
[15]
Stone JH, Merkel PA, Spiera R, et al. Rituximab versus cyclophosphamide for ANCA-associated vasculitis[J]. N Engl J Med, 2010, 363(3): 221-232.
[16]
Specks U, Merkel PA, Seo P, et al. Efficacy of remission-induction regimens for ANCA- regimens for ANCA-associated vasculitis[J]. N Engl J Med, 2013, 369(5): 417-427.
[17]
Guerry MJ, Brogan P, Bruce IN, et al. Recommendations for the use of rituximab in anti-neutrophil cytoplasm antibody-associated vasculitie[J]. Rheumatology (Oxford), 2012, 51(4): 634-643.
[18]
Charles P, Bienvenu B, Bonnotte B, et al. Rituximab: recommendations of the French vasculitis study group (FVSG) for induction and maintenance treatments of adult, antineutrophil cytoplasm antibody-associated necrotizing vasculitides[J]. Presse Med, 2013, 42(10): 1317-1330.
[19]
Josselin L, Mahr A, Cohen P, et al. Infliximab efficacy and safety against refractory systemic becrotising vasculitides: long-term follow-up of 15 patients[J]. Ann Rheum Dis, 2008, 67(9): 1343-1346.
[20]
Morgan MD, Drayson MT, Savage CO, et al. Addition of inflixinab to standard therapy for ANCA-associated vasculitis[J]. Nephron Clin Pract, 2011, 117(2): c89-c97.
[21]
Ramos-Casals M, Brito-Zeron P, Munoz S, et al. A systematic review of the off-label use of biological therapies in systemic autoimmune diseases[J]. Medicine (Baltimore), 2008, 87(6): 345-364.
[22]
Chen TJ, Yang YF, Huang PH, et al. Permanent renal loss following tumor necrosis factor-α antagonists for arthritis[J]. Rheumatol Int, 2010, 30(8): 1077-1079.
[23]
Walsh M, Chaudhry A, Jayne D. Long-term follow-up of relapsing/refractory anti-neutrophil cytoplasm antibody associated vasculitis treated with the lymphocyte depleting antibody alemtuzumab (CAMPATH-IH)[J]. Ann Rheum Dis, 2008, 67(9): 322-327.
[24]
Schmitt WH, Hagen EC, Neumann I, et al. Treatment of refractory Wegener's granulomatosis with antithymocyte globulin (ATG): an open study in 15 patients[J]. Kidney Int, 2004, 65(4): 1440-1448.
[25]
Kim S, Marigowda G, Oren E, et al. Mepolizumab as a steroid-sparing treatment option in patients with Churg-Strauss syndrome[J]. J Allergy Clin Immunol, 2010, 125(6): 1336-1343.
[26]
Stone JH, Uhlfelder ML, Hellmann DB, et al. Etanercept combined with conventional treatment in Wegener's granulomatosis: a six-month open-label trial to evaluate safety[J]. Arthritis Rheum, 2001, 44(5): 1149-1154.
[27]
Wegener's Granulomatosis Etanercept Trial (WGET) research group. Ertanercept plus standard therapy for Wegener's granulomatosi[J]. N Engl J Med, 2005, 352(4): 351-361.
[28]
Laurino S, Chaudhry A, Booth A, et al. Prospective study of TNFalpha blockade with adalimumab in ANCA-associated systemic vasculitis with renal involvement[J]. Nephrol Dial Transplant, 2010, 25(10): 3307-3314.
2018年第39卷第10期
8
1
0
引用本文
BibTeX
文章信息
doi: 10.13683/j.wph.2018.10.004
  • 接收时间:2018-05-25
  • 首发时间:2026-11-18
  • 出版时间:2018-10-10
补充材料
相关文章
文章信息
作者
出版历史
  • 收稿日期:2018-05-25
  • 修回日期:2018-08-29
基金
作者信息
    复旦大学附属金山医院肾内科,上海 201508
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2018.10.004
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏